VIIV HEALTHCARE COMPANY

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
C07D HETEROCYCLIC COMPOUNDS 22140
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 17238
 
 
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 268

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0369,509 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITYSep 07, 17Dec 28, 17[A61K, C07D]
2017/0281,636 ANTIVIRAL THERAPYJun 13, 17Oct 05, 17[A61K]
2017/0216,284 ANTIVIRAL THERAPYApr 19, 17Aug 03, 17[A61K]
2017/0079,982 ANTIVIRAL THERAPYDec 01, 16Mar 23, 17[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9707246 Substituted (3S,11AR)-N-[(2,4-difluorophenyl)methyl]-6-oxy-3-methyl-5,7-dioxo-2,3,5,7,11,11A-hexahydro[1,3]oxazolo[3,2-A]pyrido[1,2-D]pyrazine-8-carboxamides as HIV agentsAug 05, 15Jul 18, 17[A61K, C07F, C07D]
9643981 Process for preparing (4R,12aS)-N-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12A-hexahydro-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamideJul 28, 15May 09, 17[C07D]
9365587 Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediatesNov 10, 15Jun 14, 16[A61K, C07D]
9273065 Substituted pyrido[1',2':4,5]pyrazino[1,2-a]pyrimidines as HIV integrase inhibitorsApr 30, 15Mar 01, 16[C07D]
9242986 Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediatesMay 08, 14Jan 26, 16[A61K, C07D]
9133216 (3S,11aR)-6-[(phenylmethyl)oxy]-3-methyl-2,3,11,11a-tetrahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-5,7-dione of the formula P-9 and/or (3S,11aR)-6-[(phenymethyl)oxy]-8-bromo-3-methyl-2,3,11,11a-tetrahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-5,7-dione of the formula P-10Mar 17, 15Sep 15, 15[C07D]
9120817 Process for preparing (4R,12aS)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1′ ,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acidOct 14, 14Sep 01, 15[C07D]
9051337 Substituted 10-hydroxy-9,11-dioxo-2,3,4a,5,9,11,13,13a-octahydro-1h-pyrido[1,2-a]pyrrolo[1′,2′:3,4]imidazo[1,2-d]pyrazine-8-carboxamidesMar 14, 14Jun 09, 15[A61K, C07D]
9012650 Substituted (3S, 11aR)-N-[(2,4-difluorophenyl)methyl]-6-oxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamides of formula (I) useful as HIV agentsMay 21, 14Apr 21, 15[A61K, C07F, C07D]
8981129 2-(2-hydroxy-2-phenylethyl)-3-[(phenylmethyl)oxy]-4H-pyran-4-one of the formula P-3 and/or 2-[(E)-2-phenylethenyl]-3-[(phenylmethyl)oxy]-4H-Pyran-4-one of the formula P-4May 20, 14Mar 17, 15[C07F, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0267,693 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITYAbandonedMay 18, 17Sep 21, 17[A61K, C07D]
2017/0260,203 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITYAbandonedMay 18, 17Sep 14, 17[A61K, C07D]
2017/0253,616 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITYAbandonedMay 17, 17Sep 07, 17[A61K, C07D]
2017/0224,694 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITYAbandonedApr 27, 17Aug 10, 17[A61K]
2017/0224,695 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITYAbandonedApr 27, 17Aug 10, 17[A61K]
2017/0209,454 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITYAbandonedApr 10, 17Jul 27, 17[A61K]
2017/0145,033 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITYAbandonedFeb 08, 17May 25, 17[C07D]
2017/0119,777 ANTIVIRAL THERAPYAbandonedDec 01, 16May 04, 17[A61K]
2017/0029,438 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITYAbandonedOct 11, 16Feb 02, 17[A61K, C07D]
2016/0339,033 ANTIVIRAL THERAPYAbandonedAug 01, 16Nov 24, 16[A61K]
2016/0304,535 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITYAbandonedJun 29, 16Oct 20, 16[C07D]
2016/0207,939 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITYAbandonedMar 31, 16Jul 21, 16[C07D]
2016/0199,379 ANTIVIRAL THERAPYAbandonedMar 18, 16Jul 14, 16[A61K]
2016/0137,666 SUBSTITUTED CYCLOPENTA[4,5]OXAZOLO[3,2-a]PYRIDO[1,2-d]PYRAZINES AS HIV INTEGRASE INHIBITORSAbandonedJan 20, 16May 19, 16[C07D]
2015/0238,496 ANTIVIRAL THERAPYAbandonedMay 13, 15Aug 27, 15[A61K]
2014/0256,713 2-OXONAPHTHYRIDINE-3-CARBOXAMIDES HIV INTEGRASE INHIBITORSAbandonedFeb 21, 14Sep 11, 14[C07D]
2013/0171,214 Pharmaceutical CompositionsAbandonedSep 15, 11Jul 04, 13[A61K]
2012/0295,898 Antiviral TherapyAbandonedJan 24, 11Nov 22, 12[A61K, A61P]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.